AbLang empowers researchers with capabilities like embeddings, sequence restoration, and likelihood computation, directly catering to the unique structural and functional attributes of heavy/light-chain antibodies. AbLang's deep learning framework, trained on an extensive collection of heavy-chain antibody sequences, offers unparalleled insights into their design and optimization for therapeutic applications.